Wyden, Senate Democrats, Press Pharmaceutical Companies for Evidence of Cost Savings for Americans Following Secret Deals with Trump
Senate Democrats Continue Probe Into Trump’s Sweetheart Deals for Big Pharma, Seeking Evidence That American Taxpayers Will Benefit from Lower Costs Text of the Letter (PDF) Washington, D.C. – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., led 6 Senate […]
